A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection-Reference-Cited by-同舟云学术

A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection

Published:2018-04-16 Issue:5 Volume:24 Page:610-616
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Gautam Rajeev,Nishimura Yoshiaki,Gaughan Natalie,Gazumyan Anna,Schoofs Till,Buckler-White Alicia,Seaman Michael S.,Swihart Bruce J.,Follmann Dean A.,Nussenzweig Michel C.,Martin Malcolm A.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0001-2.pdf

Reference36 articles.

1. Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466–470 (2011).

2. Walker, L. M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285–289 (2009).

3. Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856–861 (2010).

4. Liao, H. X. et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469–476 (2013).

5. Scheid, J. F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633–1637 (2011).

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies;Journal of Experimental Medicine;2024-09-05

2. The Current Pipeline of Antiretroviral Therapy;Infectious Disease Clinics of North America;2024-09

3. HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies;2024-05-09

4. Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS;JCI Insight;2024-04-08

5. In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies;Nature Biomedical Engineering;2024-03-14